CBUS
Price
$1.31
Change
+$0.01 (+0.77%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
68.3M
RXRX
Price
$4.72
Change
+$0.09 (+1.94%)
Updated
Sep 26 closing price
Capitalization
2.06B
39 days until earnings call
Interact to see
Advertisement

CBUS vs RXRX

Header iconCBUS vs RXRX Comparison
Open Charts CBUS vs RXRXBanner chart's image
Cibus
Price$1.31
Change+$0.01 (+0.77%)
Volume$800
Capitalization68.3M
Recursion Pharmaceuticals
Price$4.72
Change+$0.09 (+1.94%)
Volume$39.34M
Capitalization2.06B
CBUS vs RXRX Comparison Chart in %
Loading...
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CBUS vs. RXRX commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBUS is a Hold and RXRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CBUS: $1.30 vs. RXRX: $4.72)
Brand notoriety: CBUS and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CBUS: 63% vs. RXRX: 183%
Market capitalization -- CBUS: $68.3M vs. RXRX: $2.06B
CBUS [@Biotechnology] is valued at $68.3M. RXRX’s [@Biotechnology] market capitalization is $2.06B. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBUS’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • CBUS’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, both CBUS and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBUS’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • CBUS’s TA Score: 4 bullish, 4 bearish.
  • RXRX’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than CBUS.

Price Growth

CBUS (@Biotechnology) experienced а -8.45% price change this week, while RXRX (@Biotechnology) price change was -3.87% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

RXRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.06B) has a higher market cap than CBUS($68.3M). RXRX YTD gains are higher at: -30.178 vs. CBUS (-52.878). CBUS has higher annual earnings (EBITDA): -262.49M vs. RXRX (-583.64M). RXRX has more cash in the bank: 525M vs. CBUS (36.5M). CBUS has less debt than RXRX: CBUS (35.4M) vs RXRX (88.1M). RXRX has higher revenues than CBUS: RXRX (64.5M) vs CBUS (4.85M).
CBUSRXRXCBUS / RXRX
Capitalization68.3M2.06B3%
EBITDA-262.49M-583.64M45%
Gain YTD-52.878-30.178175%
P/E RatioN/AN/A-
Revenue4.85M64.5M8%
Total Cash36.5M525M7%
Total Debt35.4M88.1M40%
FUNDAMENTALS RATINGS
CBUS: Fundamental Ratings
CBUS
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
16
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
90

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CBUSRXRX
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 18 days ago
85%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 12 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSMAX10.430.11
+1.07%
SEI Small/Mid Cap Equity A (SIIT)
QCACX45.640.27
+0.60%
Federated Hermes MDT All Cap Core C
GAGIX36.090.19
+0.53%
Gabelli Global Rising Income and Div I
TIBOX31.930.15
+0.47%
Thornburg Investment Income Builder R6
CGCIX14.660.03
+0.21%
Calamos Global Opportunities I

CBUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBUS has been loosely correlated with RXRX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CBUS jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBUS
1D Price
Change %
CBUS100%
+0.77%
RXRX - CBUS
37%
Loosely correlated
+2.05%
CGEM - CBUS
36%
Loosely correlated
-0.67%
ARCT - CBUS
35%
Loosely correlated
+9.11%
CRBU - CBUS
33%
Loosely correlated
+10.36%
FHTX - CBUS
33%
Poorly correlated
+3.41%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+1.94%
CRSP - RXRX
68%
Closely correlated
+2.24%
ABSI - RXRX
63%
Loosely correlated
+3.02%
BEAM - RXRX
61%
Loosely correlated
-0.52%
ABCL - RXRX
58%
Loosely correlated
+1.94%
NTLA - RXRX
54%
Loosely correlated
-1.81%
More